Harbour Investments’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.1K Buy
217
+84
+63% +$7.14K ﹤0.01% 3045
2026
Q1
$11.5K Buy
133
+130
+4,333% +$11.7K ﹤0.01% 3188
2025
Q4
$262 Buy
+3
New +$228 ﹤0.01% 3644
2025
Q2
Sell
-20
Closed -$1.46K 3651
2025
Q1
$1.46K Sell
20
-5
-20% -$413 ﹤0.01% 3155
2024
Q4
$2.07K Buy
25
+5
+25% +$394 ﹤0.01% 3012
2024
Q3
$1.43K Buy
+20
New +$1.41K ﹤0.01% 3018
2021
Q4
$4K Sell
60
-625
-91% -$45.4K ﹤0.01% 2233
2021
Q3
$52K Sell
685
-2,027
-75% -$163K ﹤0.01% 1739
2021
Q2
$210K Hold
2,712
0.01% 1019
2021
Q1
$167K Buy
+2,712
New +$172K 0.01% 1057

Other funds holding GMED

Harbour Investments's GMED Position: Q2 2026 in Review

Harbour Investments increased its Globus Medical (GMED) stake by 63% in Q2 2026, buying an estimated $7.14K and bringing the position to 217 shares worth $17.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3045.

Harbour Investments first reported a position in GMED in Q1 2021 and has held it in 10 quarters since. The position peaked at $210K in Q2 2021. 596 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Harbour Investments held 217 shares of Globus Medical worth $17.1K as of Q2 2026.
  • Harbour Investments bought 84 Globus Medical shares in Q2 2026, an estimated $7.14K.
  • Globus Medical made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #3045 holding.
  • Harbour Investments first reported a position in Globus Medical in Q1 2021 and has held it in 10 quarters since.
  • Harbour Investments's Globus Medical position peaked at $210K in Q2 2021.
  • 596 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.